Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quetiapine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1239487C reveals a novel route for Quetiapine intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity API production.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Patent CN103724294A reveals a novel route for Quetiapine intermediates, eliminating high-temperature distillation to ensure superior purity and supply chain stability.
Patent CN109384744A enables direct synthesis of Quetiapine intermediate with high purity. Reduces steps and cost for pharmaceutical manufacturing supply chains globally.
Advanced synthesis of Quetiapine Hemifumarate via novel thiosalicylic acid route. High yield, eco-friendly process for cost-effective API manufacturing.
Novel synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Reduces toxicity and improves yield for API manufacturing.
Advanced synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Offers mild conditions, high purity, and cost reduction in API manufacturing.
Patent CN114380769A reveals a novel one-step chlorination route for 9-chloroquetiapine, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112939892B reveals a green ruthenium-catalyzed route for quetiapine intermediates, offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN1177839C details a robust Quetiapine synthesis avoiding unstable intermediates. This report analyzes cost reduction and scalability for pharmaceutical manufacturing.